UIMZ:F:F-UBS (Lux) Fund Solutions - Factor MSCI EMU Prime Value UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 19.92

Change

+0.28 (+1.43)%

Market Cap

USD 0.14B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+15.83 (+3.24%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.73 (+1.51%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.85 (+1.61%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.22 (+1.52%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.95 (+1.36%)

USD 45.80B
0ZC:F Zscaler Inc

+6.74 (+3.99%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.69%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing UIMZ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.56% 80% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.56% 80% B- 70% C-
Trailing 12 Months  
Capital Gain 1.56% 55% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.56% 53% F 52% F
Trailing 5 Years  
Capital Gain 58.22% 62% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.22% 62% D 46% F
Average Annual (5 Year Horizon)  
Capital Gain 7.34% 60% D- 59% D-
Dividend Return 7.34% 57% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.45% 54% F 86% B+
Risk Adjusted Return 58.99% 59% D- 71% C-
Market Capitalization 0.14B 39% F 34% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.